Bitterroot Bio
PrivateLast Round
Series A
Jun 7, 2023
Total Funding Raised
$145M
Company Overview
Bitterroot Bio operates in Healthcare & Life Sciences and is based in Palo Alto, California. Its latest recorded funding round was a Series A round in June 2023.
Bitterroot Bio is a biotechnology company that develops novel immunotherapies for the treatment of cardiovascular disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bitterroot Bio Comparables
Compare Bitterroot Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cardurion Pharmaceuticals | 84% | |
| POLYGON Therapeutics | 84% | |
| Cyclarity Therapeutics | 83% |
For institutional investors. Book with your work email.
Bitterroot Bio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Bitterroot Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deerfield Management | Series A |
| GV | Series A |
| ARCH Venture Partners | Series A |
| Koch Disruptive Technologies | Series A |
| Alexandria Venture Investments | Series A |
| Koch Disruptive Technologies | Series A |
| Alexandria Venture Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 17, 2025
Phase 1 results for BRB-002 to be presented at ACC 2025.
- Mar 17, 2025
Will present at the American College of Cardiology Annual Scientific Session 2025.
For institutional investors. Book with your work email.
Bitterroot Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Bitterroot Bio's valuation, stock price, and market status.
Is Bitterroot Bio a public or private company?
Bitterroot Bio is a private company.
What is the current stock price of Bitterroot Bio?
Bitterroot Bio is a private company, so its shares have no public market price. Caplight tracks Bitterroot Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Bitterroot Bio worth (valuation)?
Valuation information for Bitterroot Bio is not publicly available.
Can I buy Bitterroot Bio stock?
Bitterroot Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Bitterroot Bio's last funding round?
Bitterroot Bio's most recent funding round was Series A on June 7, 2023.
Who are the main investors in Bitterroot Bio?
Key investors in Bitterroot Bio include Deerfield Management, ARCH Venture Partners.
Will Bitterroot Bio IPO soon?
No public IPO plans have been announced for Bitterroot Bio.
How can I track Bitterroot Bio secondary market activity?
Caplight tracks bids, offers, and trades in Bitterroot Bio's shares on secondary markets.